Terug
Dagbereik
€ 8,95
€ 11,00
52-Weeksbereik
€ 8,95
€ 12,95
Volume
100
50D / 200D Gem.
€ 11,67
/
€ 12,63
Vorige Slotkoers
€ 8,95
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 12,3 | 0,2 |
| P/B | 1,9 | 3,0 |
| ROE % | 16,4 | 3,6 |
| Net Margin % | 7,2 | 3,8 |
| Rev Growth 5Y % | 2,6 | 9,9 |
| D/E | 1,3 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 1,12
€ 1,07 – € 1,21
|
1,57B | 1 |
| FY2028 |
€ 1,15
€ 1,10 – € 1,24
|
1,55B | 1 |
| FY2027 |
€ 1,06
€ 1,02 – € 1,15
|
1,50B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-13 | € 0,29 | € 0,19 | -35,7% |
| 2025-10-23 | € 0,18 | € 0,16 | -7,0% |
| 2025-07-17 | € 0,24 | € 0,20 | -17,9% |
| 2025-04-25 | € 0,25 | € 0,29 | +17,4% |
| 2025-02-14 | € 0,23 | € 0,16 | -31,1% |
| 2024-10-25 | € 0,10 | € 0,13 | +22,2% |
| 2024-07-17 | € 0,15 | € 0,12 | -17,6% |
| 2024-04-26 | € 0,15 | € 0,20 | +30,7% |
Dividend History
7 yr streakYield
0,04%
Payout Ratio
0,66%
Growth (3Y)
24,14%
Growth (5Y)
30,46%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Oct 08, 2026 | Oct 15, 2026 | € 0,37 | 8,30% |
| Mar 26, 2026 | Apr 08, 2026 | € 0,37 | 7,33% |
| Oct 08, 2025 | Oct 15, 2025 | € 0,28 | 4,37% |
| Apr 10, 2025 | Apr 17, 2025 | € 0,27 | 3,52% |
| Oct 09, 2024 | Oct 16, 2024 | € 0,16 | 2,71% |
| Mar 27, 2024 | Apr 08, 2024 | € 0,16 | 2,62% |
| Sep 29, 2023 | Oct 09, 2023 | € 0,15 | 2,53% |
| Mar 24, 2023 | Apr 03, 2023 | € 0,15 | 2,53% |
| Oct 07, 2022 | Oct 19, 2022 | € 0,14 | 2,53% |
| Apr 08, 2022 | Apr 20, 2022 | € 0,15 | 2,44% |
| Oct 29, 2021 | Nov 10, 2021 | € 0,15 | 2,29% |
| Mar 26, 2021 | Apr 07, 2021 | € 0,15 | 2,29% |
| Jul 01, 2020 | Jul 09, 2020 | € 0,15 | 1,44% |
| Apr 05, 2019 | Apr 15, 2019 | € 0,22 | 2,38% |
| Apr 13, 2018 | Apr 27, 2018 | € 0,07 | 0,60% |
Belangrijkste Punten
Revenue grew 2,58% annually over 5 years — modest growth
Earnings grew 29,10% over the past year
ROE of 16,35% — decent returns on equity
Generating 156,34M in free cash flow
P/E of 12,25 — trading at a low valuation
PEG of 0,54 suggests growth is underpriced
Groei
Revenue Growth (5Y)
2,58%
Revenue (1Y)-4,60%
Earnings (1Y)29,10%
FCF Growth (3Y)15,60%
Kwaliteit
Return on Equity
16,35%
ROIC7,82%
Net Margin7,24%
Op. Margin10,76%
Veiligheid
Debt / Equity
1,26
Current Ratio0,64
Interest Coverage6,25
Waardering
P/E Ratio
12,25
Forward P/E9,11
P/B Ratio1,94
EV/EBITDA13,04
Dividend Yield0,04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -4,60% | Revenue Growth (3Y) | -0,31% |
| Earnings Growth (1Y) | 29,10% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 2,58% | Earnings Growth (5Y) | 3,55% |
| Profitability | |||
| Revenue (TTM) | 1,28B | Net Income (TTM) | 92,57M |
| ROE | 16,35% | ROA | 6,43% |
| Gross Margin | 21,09% | Operating Margin | 10,76% |
| Net Margin | 7,24% | Free Cash Flow (TTM) | 156,34M |
| ROIC | 7,82% | FCF Growth (3Y) | 15,60% |
| Safety | |||
| Debt / Equity | 1,26 | Current Ratio | 0,64 |
| Interest Coverage | 6,25 | ||
| Dividends | |||
| Dividend Yield | 0,04% | Payout Ratio | 0,66% |
| Dividend Growth (3Y) | 24,14% | Dividend Growth (5Y) | 30,46% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 12,25 | Forward P/E | 9,11 |
| P/B Ratio | 1,94 | P/S Ratio | 0,89 |
| PEG Ratio | 0,54 | Forward PEG | N/A |
| EV/EBITDA | 13,04 | Fwd EV/EBITDA | 6,06 |
| Forward P/S | 0,77 | Fwd Earnings Yield | 10,98% |
| FCF Yield | 13,79% | ||
| Market Cap | 1,13B | Enterprise Value | 1,79B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,28B | 1,34B | 1,29B | 1,26B | 1,15B |
| Net Income | 92,57M | 71,70M | -42,20M | 24,40M | 80,50M |
| EPS (Diluted) | 0,73 | 0,57 | -0,33 | 0,19 | 0,63 |
| Gross Profit | 269,60M | 790,20M | 303,20M | 733,40M | 665,80M |
| Operating Income | 137,55M | 116,10M | -14,70M | 33,90M | 110,10M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,44B | 1,40B | 1,42B | 1,48B | 1,45B |
| Total Liabilities | 856,68M | 850,20M | 904,10M | 887,40M | 839,70M |
| Shareholders' Equity | 583,98M | 548,20M | 515,40M | 592,00M | 608,90M |
| Total Debt | 734,82M | 570,00M | 635,80M | 607,00M | 557,30M |
| Cash & Equivalents | 75,17M | 65,20M | 37,70M | 40,20M | 38,10M |
| Current Assets | 207,62M | 208,20M | 192,60M | 189,70M | 172,80M |
| Current Liabilities | 326,08M | 312,50M | 300,30M | 306,90M | 392,00M |